
Crohn's patients surviving longer, overtreatment in spotlight
Australian Crohn’s disease patients live about as long as the general population, avoiding the 1.5 fold increased mortality found among their counterparts in other countries, according to data presented at ECCO Congress in Barcelona this week.
16 hours ago

Anti-TNF beats thiopurines in post-op CD
Adalimumab appears to be more effective than thiopurines for preventing Crohn’s disease recurrence after ileocecal resection, according to early results from the first trial prospectively comparing the two therapies.
16 hours ago